Previous 10 | Next 10 |
home / stock / nvzmy / nvzmy news
2023-10-10 21:54:11 ET Summary Novozymes' stock is declining for almost two years and has lost almost 50% of its previous value. The company reported mediocre half-year results for fiscal 2023. But Novozymes has a wide economic moat around its business, making the company a go...
2023-10-09 12:37:47 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
Novozymes Named EPA Safer Choice Partner of the Year for Third Year in a Row PR Newswire World's Leading Biotech Powerhouse Recognized for Providing and Advocating for Ingredients that Create Safer Detergents FRANKLINTON, N.C. , Oct. 3, 2023 /PRNewswire/ ...
2023-08-09 14:05:09 ET Novozymes A/S (NVZMF) 1H 2023 Earnings Conference Call August 9 2023 3:00 AM ET Company Participants Tobias Bjorklund - Head of investor relations Ester Baiget - President and CEO Lars Green - EVP and CFO Amy Byrick - EVP, Strategy and ...
2023-08-09 00:36:25 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2023-07-17 08:45:23 ET Summary Novozymes is increasing prices to counter soft demand and high costs, but end markets probably won't tolerate rising prices indefinitely. With generally weak input price inflation, Novozymes' stock price is likely to be determined by the interplay of...
2023-07-07 11:07:45 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2023-06-02 05:36:23 ET Summary Danish companies Novozymes and Christian Hansen have announced plans to merge, creating a leading global biosolutions company. The merger is expected to be completed in late 2023 or early 2024, following regulatory approval. Despite the wide econ...
2023-05-09 23:17:21 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2023-04-26 21:11:04 ET Novozymes A/S (NVZMF) Q1 2023 Earnings Conference Call April 26, 2023, 03:00 ET Company Participants Tobias Bjorklund - Head of IR Ester Baiget - President & CEO Lars Green - EVP & CFO Amy Byrick - EVP, Strategy & Business T...
News, Short Squeeze, Breakout and More Instantly...
SunPower Corporation (SPWR) is expected to report $-0.29 for Q1 2024 Siemens Healthineers AG ADR (SMMNY) is expected to report for Q2 2024 Specificity Inc Com (SPTY) is expected to report for Q1 2024 Tokyo Gas Co. Ltd. ADR (TKGSY) is expected to report for Q4 2024 Gol Linhas Aerea...
Ebix Inc. (EBIXQ) is expected to report for Q1 2024 Amesite Inc. (AMST) is expected to report for Q3 2024 Hibbett Inc. (HIBB) is expected to report $2.68 for Q1 2025 Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A) (WDH) is expected to repo...
TDCX Inc. American Depositary Shares each representing one Class A (TDCX) is expected to report for Q1 2024 nCino Inc. (NCNO) is expected to report $0 for Q1 2025 SK Telecom Co. Ltd. (SKM) is expected to report for Q1 2024 Redeia Corporacion S.A. ADR (RDEIY) is expected to report for ...